[ Price : $8.95]
A new analysis from University of California (UC) Riverside and UC Irvine researchers finds that the vast majority of pivotal clin...[ Price : $8.95]
FDA and drug-industry negotiators exchange early feedback on the agencys proposed America First fee incentives for domestic drug d...[ Price : $8.95]
FDA approves Janssens Akeega a fixed-dose combination of niraparib and abiraterone acetate with prednisone for adults with metas...[ Price : $8.95]
FDA releases the form FDA-483 with two observations from an inspection at the Astellas Pharma sterile drug manufacturing facility ...[ Price : $8.95]
Eli Lillys investigational triple-agonist retatrutide shows substantial weight loss and meaningful reductions in knee osteoarthrit...[ Price : $8.95]
Cardiovascular Business reports that the American College of Cardiology has joined numerous other healthcare organizations in aski...[ Price : $8.95]
FDA accepts for priority review a Bristol Myers Squibb supplemental BLA for Opdivo (nivolumab) and its use in combination with AVD...[ Price : $8.95]
An independent assessment of the FDA Total Product Lifecycle Advisory Program pilot finds it met its objectives exceptionally well...